title: Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease?
abstract: The pathogenesis of RA, a disabling autoimmune disease, is incompletely understood. Early in the development of RA there appears to be loss of immune homeostasis and regulation, and premature immunosenescence. While identification of risk factors and understanding of the phases of RA pathogenesis are advancing, means of accurately predicting an individual's risk of developing RA are currently lacking. Telomere length has been proposed as a potential new biomarker for the development of RA that could enhance prediction of this serious disease. Studies examining telomere length in relation to RA have found that telomere erosion appears to proceed more rapidly in subjects with RA than in healthy controls, and that telomere lengths are shorter in those with the RA-risk HLA-shared epitope genes. These studies have been small, however, with retrospective or cross-sectional designs. The potential role of telomere shortening as an independent biomarker for future RA risk, perhaps strongly genetically determined by HLA-SE genes, after controlling for known risk factors such as smoking, body mass index and immunosuppressant medication use, as well as systemic inflammation, is an unanswered question.
authors.affiliation: Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Kcostenbader@partners.org
authors.forename: Karen H
authors.initials: KH
authors.lastname: Costenbader
authors.forename: Jennifer
authors.initials: J
authors.lastname: Prescott
authors.forename: Robert Y
authors.initials: RY
authors.lastname: Zee
authors.forename: Immaculata
authors.initials: I
authors.lastname: De Vivo
mesh_terms: D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology* / Q000503:physiopathology; D006801:Humans; D011379:Prognosis; D012307:Risk Factors; D016615:Telomere / Q000235:genetics*